A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine [Xeloda]|DRUG: Taxotere|DRUG: Taxotere
Sponsor: Hoffmann-La Roche